My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1883

    1.

    A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control.

    DeVries JH, Snoek FJ, Kostense PJ, Masurel N, Heine RJ; Dutch Insulin Pump Study Group.

    Diabetes Care. 2002 Nov;25(11):2074-80.PMID: 12401759 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.

    Alemzadeh R, Palma-Sisto P, Holzum M, Parton E, Kicher J.

    Diabetes Technol Ther. 2007 Aug;9(4):339-47.PMID: 17705689 [PubMed - indexed for MEDLINE]Related articles

    3.

    Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial.

    Hoogma RP, Hammond PJ, Gomis R, Kerr D, Bruttomesso D, Bouter KP, Wiefels KJ, de la Calle H, Schweitzer DH, Pfohl M, Torlone E, Krinelke LG, Bolli GB; 5-Nations Study Group.

    Diabet Med. 2006 Feb;23(2):141-7.PMID: 16433711 [PubMed - indexed for MEDLINE]Related articles

    4.

    Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial.

    Weintrob N, Benzaquen H, Galatzer A, Shalitin S, Lazar L, Fayman G, Lilos P, Dickerman Z, Phillip M.

    Pediatrics. 2003 Sep;112(3 Pt 1):559-64.PMID: 12949284 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.

    Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV.

    Diabetes Care. 2004 Jul;27(7):1554-8.PMID: 15220227 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

    Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

    Ann Intern Med. 2008 Oct 21;149(8):531-9.PMID: 18936501 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

    Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

    Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

    8.

    Improved glycemic control with use of continuous subcutaneous insulin infusion compared with multiple insulin injection therapy.

    Bell DS, Ovalle F.

    Endocr Pract. 2000 Sep-Oct;6(5):357-60.PMID: 11141585 [PubMed - indexed for MEDLINE]Related articles

    9.

    Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.

    Alemzadeh R, Palma-Sisto P, Parton EA, Holzum MK.

    Diabetes Technol Ther. 2005 Aug;7(4):587-96.PMID: 16120030 [PubMed - indexed for MEDLINE]Related articles

    10.

    Intensive insulin therapy with insulin lispro: a randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection.

    Tsui E, Barnie A, Ross S, Parkes R, Zinman B.

    Diabetes Care. 2001 Oct;24(10):1722-7.PMID: 11574432 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Improved glycemic control with intraperitoneal versus subcutaneous insulin in type 1 diabetes: a randomized controlled trial.

    Logtenberg SJ, Kleefstra N, Houweling ST, Groenier KH, Gans RO, van Ballegooie E, Bilo HJ.

    Diabetes Care. 2009 Aug;32(8):1372-7. Epub 2009 May 8.PMID: 19429874 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.

    Roach P, Bai S, Charbonnel B, Consoli A, Taboga C, Tiengo A, Bolli G; High Mix Study Group.

    Clin Ther. 2004 Apr;26(4):502-10.PMID: 15189747 [PubMed - indexed for MEDLINE]Related articles

    13.

    A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes.

    Herman WH, Ilag LL, Johnson SL, Martin CL, Sinding J, Al Harthi A, Plunkett CD, LaPorte FB, Burke R, Brown MB, Halter JB, Raskin P.

    Diabetes Care. 2005 Jul;28(7):1568-73.PMID: 15983302 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Long-term therapy of IDDM with an implantable insulin pump. The Implantable Insulin Pump Trial Study Group.

    Dunn FL, Nathan DM, Scavini M, Selam JL, Wingrove TG.

    Diabetes Care. 1997 Jan;20(1):59-63.PMID: 9028695 [PubMed - indexed for MEDLINE]Related articles

    15.

    Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group.

    Saudek CD, Duckworth WC, Giobbie-Hurder A, Henderson WG, Henry RR, Kelley DE, Edelman SV, Zieve FJ, Adler RA, Anderson JW, Anderson RJ, Hamilton BP, Donner TW, Kirkman MS, Morgan NA.

    JAMA. 1996 Oct 23-30;276(16):1322-7.PMID: 8861991 [PubMed - indexed for MEDLINE]Related articles

    16.

    A comparison of insulin lispro and buffered regular human insulin administered via continuous subcutaneous insulin infusion pump.

    Raskin P, Holcombe JH, Tamborlane WV, Malone JI, Strowig S, Ahern JA, Lavent F.

    J Diabetes Complications. 2001 Nov-Dec;15(6):295-300.PMID: 11711322 [PubMed - indexed for MEDLINE]Related articles

    17.

    Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.

    Hanaire-Broutin H, Melki V, Bessières-Lacombe S, Tauber JP.

    Diabetes Care. 2000 Sep;23(9):1232-5.PMID: 10977011 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Beneficial effects of continuous subcutaneous insulin infusion in older patients with long-standing type 1 diabetes.

    Rizvi AA, Petry R, Arnold MB, Chakraborty M.

    Endocr Pract. 2001 Sep-Oct;7(5):364-9.PMID: 11585372 [PubMed - indexed for MEDLINE]Related articles

    19.

    A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes.

    Hamann A, Matthaei S, Rosak C, Silvestre L; HOE901/4007 Study Group.

    Diabetes Care. 2003 Jun;26(6):1738-44.PMID: 12766103 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion.

    Weintrob N, Schechter A, Benzaquen H, Shalitin S, Lilos P, Galatzer A, Phillip M.

    Arch Pediatr Adolesc Med. 2004 Jul;158(7):677-84.PMID: 15237068 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity